Chemomab Therapeutics
Clinical-stage biotech company focusing on the discovery and development of innovative therapeutics. Learn more
Launch date
Employees
Market cap
€23.3m
Enterprise valuation
€12m (Public information from Sep 2024)
Share price
$1.68 CMMB
Tel Aviv-Yafo Tel Aviv District (HQ)
Authorizing premium user...